Medtronic (MDT) Begins Enrollment in IDE Study of PLGM Technology
Tweet Send to a Friend
Medtronic (NYSE: MDT) announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE